COX-2 and Non-Selective NSAID Use in Those at Increased Risk of NSAID-Related Adverse Events

被引：0
|
作者：
Ilomaki, Jenni [1 ]
Gadzhanova, Svetla [1 ]
Roughead, Elizabeth E. [1 ]
机构：
[1] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Qual Use Med & Phrmacy Res Ctr, Adelaide, SA 5001, Australia
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2012年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
145
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [41] Adverse lower gastrointestinal effects of non-selective and COX-2 selective NSAIDs: A systematic review
    Laine, Loren
    Smith, Rebecca A.
    Min, Kejia
    Chen, Connie
    Dubois, Robert W.
    GASTROENTEROLOGY, 2006, 130 (04) : A303 - A304
  • [42] Risk of stroke in arthritis patients treated with cox-2 selective and non-selective NSAIDs
    Graham, David J.
    Singh, Gurkirpal
    Wang, H.
    Mannalithara, A.
    Lingala, V.
    Mithal, Alka
    Triadafilopoulos, George
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S67 - S67
  • [43] Non-selective NSAIDs and COX-2 selective inhibitors: GI risk and use of proton pump inhibitor prophylaxis
    Ofman, JJ
    Badamgarav, E
    Knight, K
    Henning, JM
    Wallace, K
    Wong, J
    Dylan, M
    Laine, L
    GASTROENTEROLOGY, 2003, 124 (04) : A107 - A107
  • [44] Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers
    Brzozowski, T
    Konturek, PC
    Konturek, SJ
    Sliwowski, Z
    Pajdo, R
    Drozdowicz, D
    Ptak, A
    Kahn, EG
    MICROSCOPY RESEARCH AND TECHNIQUE, 2001, 53 (05) : 343 - 353
  • [45] COX-2 inhibitors, nonselective NSAID use increases risk of death, reinfarction in acute MI patients
    不详
    FORMULARY, 2006, 41 (08) : 368 - +
  • [46] An analysis from clinico-epidemiological data of the principal adverse events from the COX-2 selective NSAID, nimesulide, with particular reference to hepatic injury
    Rainsford K.D.
    InflammoPharmacology, 1998, 6 (3) : 203 - 221
  • [47] Wound collagen deposition in rats:: effects of an NO-NSAID and a selective COX-2 inhibitor
    Muscará, MN
    McKnight, W
    Asfaha, S
    Wallace, JL
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (04) : 681 - 686
  • [48] Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review
    Schaffer, Delia
    Florin, Timothy
    Eagle, Craig
    Marschner, Ian
    Singh, Gurkirpal
    Grobler, Mendel
    Fenn, Chris
    Schou, Manjula
    Curnow, Kathleen M.
    MEDICAL JOURNAL OF AUSTRALIA, 2006, 185 (09) : 501 - 506
  • [49] Discovery of novel inhibitors of human COX-2 structurally related to the NSAID etodolac (LODINE)
    Kreft, A
    Caufield, C
    Failli, A
    Caggiano, T
    Greenfield, A
    Kubrak, D
    Steffan, R
    von Burg, G
    Banker, A
    Bleyman, O
    Hu, D
    Belfast, M
    Carlson, R
    Hartman, D
    Sung, ML
    Glaser, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1215 - U1215
  • [50] Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers in rats
    Konturek, SJ
    Sliwowski, Z
    Brzozowski, T
    Konturek, PC
    Pajdo, R
    Drozdowicz, D
    Stachura, J
    Hahn, EG
    GASTROENTEROLOGY, 1999, 116 (04) : A220 - A220
12345